

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 8.83659562 |
| 2 | actin-myosin filament sliding (GO:0033275) | 8.83659562 |
| 3 | sarcomere organization (GO:0045214) | 8.49919971 |
| 4 | cardiac myofibril assembly (GO:0055003) | 8.42298571 |
| 5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.33175930 |
| 6 | myofibril assembly (GO:0030239) | 7.63057604 |
| 7 | actin-mediated cell contraction (GO:0070252) | 7.41020776 |
| 8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.36543538 |
| 9 | cardiac muscle contraction (GO:0060048) | 6.52703604 |
| 10 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.42625886 |
| 11 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.18020846 |
| 12 | regulation of skeletal muscle contraction (GO:0014819) | 6.13759059 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.12803965 |
| 14 | * cardiac muscle cell development (GO:0055013) | 5.94514617 |
| 15 | actomyosin structure organization (GO:0031032) | 5.83899492 |
| 16 | plasma membrane repair (GO:0001778) | 5.80952917 |
| 17 | tricarboxylic acid cycle (GO:0006099) | 5.80173562 |
| 18 | striated muscle contraction (GO:0006941) | 5.75010371 |
| 19 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.71873107 |
| 20 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.67876293 |
| 21 | regulation of sarcomere organization (GO:0060297) | 5.65476216 |
| 22 | regulation of relaxation of muscle (GO:1901077) | 5.62590682 |
| 23 | * cardiac cell development (GO:0055006) | 5.57487883 |
| 24 | actin filament-based movement (GO:0030048) | 5.57384997 |
| 25 | cardiac muscle hypertrophy (GO:0003300) | 5.48919732 |
| 26 | regulation of actin filament-based movement (GO:1903115) | 5.47834640 |
| 27 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.44617195 |
| 28 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.40968641 |
| 29 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.33061714 |
| 30 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.30464226 |
| 31 | muscle tissue morphogenesis (GO:0060415) | 5.28875769 |
| 32 | adult heart development (GO:0007512) | 5.24313099 |
| 33 | striated muscle hypertrophy (GO:0014897) | 5.24276924 |
| 34 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.22383897 |
| 35 | heart process (GO:0003015) | 5.17917622 |
| 36 | heart contraction (GO:0060047) | 5.17917622 |
| 37 | heart trabecula formation (GO:0060347) | 5.16147270 |
| 38 | regulation of cell communication by electrical coupling (GO:0010649) | 5.11079110 |
| 39 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 5.05807585 |
| 40 | regulation of striated muscle contraction (GO:0006942) | 4.95073317 |
| 41 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.91013565 |
| 42 | carnitine shuttle (GO:0006853) | 4.86773151 |
| 43 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.78686112 |
| 44 | regulation of membrane repolarization (GO:0060306) | 4.75018441 |
| 45 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.75007983 |
| 46 | muscle hypertrophy (GO:0014896) | 4.59859732 |
| 47 | regulation of the force of heart contraction (GO:0002026) | 4.49490094 |
| 48 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.46146412 |
| 49 | cardiac ventricle formation (GO:0003211) | 4.44581359 |
| 50 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.44476572 |
| 51 | cell communication involved in cardiac conduction (GO:0086065) | 4.37561289 |
| 52 | skeletal muscle contraction (GO:0003009) | 4.35264647 |
| 53 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.30253796 |
| 54 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.29861131 |
| 55 | ventricular cardiac muscle cell development (GO:0055015) | 4.24238257 |
| 56 | regulation of coenzyme metabolic process (GO:0051196) | 4.24216749 |
| 57 | regulation of cofactor metabolic process (GO:0051193) | 4.24216749 |
| 58 | cell communication by electrical coupling (GO:0010644) | 4.23469229 |
| 59 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.20991051 |
| 60 | muscle hypertrophy in response to stress (GO:0003299) | 4.20991051 |
| 61 | cardiac muscle adaptation (GO:0014887) | 4.20991051 |
| 62 | regulation of cardioblast differentiation (GO:0051890) | 4.14594111 |
| 63 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.14071444 |
| 64 | ATP synthesis coupled proton transport (GO:0015986) | 4.14071444 |
| 65 | fatty acid transmembrane transport (GO:1902001) | 4.13686597 |
| 66 | muscle contraction (GO:0006936) | 3.98982359 |
| 67 | negative regulation of potassium ion transport (GO:0043267) | 3.97157259 |
| 68 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.94448623 |
| 69 | * striated muscle cell development (GO:0055002) | 3.89620910 |
| 70 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.89152025 |
| 71 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.85164358 |
| 72 | cardiac muscle cell action potential (GO:0086001) | 3.84274118 |
| 73 | regulation of cardiac muscle contraction (GO:0055117) | 3.81435803 |
| 74 | oxidative phosphorylation (GO:0006119) | 3.79021025 |
| 75 | muscle system process (GO:0003012) | 3.70890391 |
| 76 | negative regulation of protein localization to cell surface (GO:2000009) | 3.68460848 |
| 77 | striated muscle adaptation (GO:0014888) | 3.67436553 |
| 78 | * regulation of heart rate (GO:0002027) | 3.66738103 |
| 79 | cardiac chamber formation (GO:0003207) | 3.64114385 |
| 80 | relaxation of cardiac muscle (GO:0055119) | 3.61152788 |
| 81 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.58046566 |
| 82 | muscle cell fate commitment (GO:0042693) | 3.57401207 |
| 83 | regulation of ATP catabolic process (GO:1903289) | 3.56652731 |
| 84 | regulation of ATPase activity (GO:0043462) | 3.56652731 |
| 85 | atrial septum morphogenesis (GO:0060413) | 3.56103881 |
| 86 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.55209764 |
| 87 | regulation of muscle contraction (GO:0006937) | 3.48341257 |
| 88 | respiratory electron transport chain (GO:0022904) | 3.47157756 |
| 89 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.46948624 |
| 90 | trabecula formation (GO:0060343) | 3.45758373 |
| 91 | response to muscle activity (GO:0014850) | 3.45530762 |
| 92 | carnitine transmembrane transport (GO:1902603) | 3.43265710 |
| 93 | muscle fiber development (GO:0048747) | 3.42335335 |
| 94 | cardiac conduction (GO:0061337) | 3.41870757 |
| 95 | response to inactivity (GO:0014854) | 3.39756825 |
| 96 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.39326926 |
| 97 | * muscle cell development (GO:0055001) | 3.37058683 |
| 98 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.36919124 |
| 99 | electron transport chain (GO:0022900) | 3.36446330 |
| 100 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.34765242 |
| 101 | outflow tract septum morphogenesis (GO:0003148) | 3.32984818 |
| 102 | regulation of cardioblast proliferation (GO:0003264) | 3.32203788 |
| 103 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.32203788 |
| 104 | regulation of sulfur metabolic process (GO:0042762) | 3.31322858 |
| 105 | regulation of muscle system process (GO:0090257) | 3.30278870 |
| 106 | relaxation of muscle (GO:0090075) | 3.30256462 |
| 107 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.29517848 |
| 108 | * regulation of heart contraction (GO:0008016) | 3.27573554 |
| 109 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.27496936 |
| 110 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.27496936 |
| 111 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.27069362 |
| 112 | response to caffeine (GO:0031000) | 3.26409530 |
| 113 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.17222281 |
| 114 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.16244265 |
| 115 | myotube cell development (GO:0014904) | 3.12980263 |
| 116 | cardiac muscle tissue development (GO:0048738) | 3.11640557 |
| 117 | positive regulation of myoblast differentiation (GO:0045663) | 3.06699820 |
| 118 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.05256965 |
| 119 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.05256965 |
| 120 | positive regulation of cation channel activity (GO:2001259) | 3.04795422 |
| 121 | skeletal muscle fiber development (GO:0048741) | 3.01512588 |
| 122 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.00541815 |
| 123 | skeletal muscle tissue development (GO:0007519) | 2.96836138 |
| 124 | muscle cell cellular homeostasis (GO:0046716) | 2.94534343 |
| 125 | regulation of myoblast differentiation (GO:0045661) | 2.86574163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.95848271 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.66125581 |
| 3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.46951499 |
| 4 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.08041711 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.08041711 |
| 6 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.99022715 |
| 7 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.59993555 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.52560978 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.30862205 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.01631069 |
| 11 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.89153734 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.86184871 |
| 13 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.82586124 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.81353234 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.75897531 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.30614305 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.19068055 |
| 18 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.15533533 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.12434520 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.11691415 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.10138271 |
| 22 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.04155333 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 2.03911980 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.02012769 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.00615589 |
| 26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.96230935 |
| 27 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.89502909 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.85841070 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.77851441 |
| 30 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.76478645 |
| 31 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.74479923 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72004454 |
| 33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71933271 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.71243888 |
| 35 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.68631071 |
| 36 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.65942953 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63742642 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57900564 |
| 39 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.57557330 |
| 40 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.57371975 |
| 41 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.56161567 |
| 42 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.54333133 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.53919387 |
| 44 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.53779318 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50509342 |
| 46 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.50477440 |
| 47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.50088247 |
| 48 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.49006521 |
| 49 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.48319772 |
| 50 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47610908 |
| 51 | FUS_26573619_Chip-Seq_HEK293_Human | 1.46672154 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.46484394 |
| 53 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.45975125 |
| 54 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.45691454 |
| 55 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.43860579 |
| 56 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.42929519 |
| 57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.42401230 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40734446 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.39221949 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38978111 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37794656 |
| 62 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.37668674 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37375032 |
| 64 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.37244723 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36613363 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34376152 |
| 67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.34253433 |
| 68 | TP53_16413492_ChIP-PET_HCT116_Human | 1.33548787 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33318893 |
| 70 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.33167430 |
| 71 | CJUN_26792858_Chip-Seq_BT549_Human | 1.33128150 |
| 72 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32350015 |
| 73 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.31707066 |
| 74 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.31635370 |
| 75 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.29658562 |
| 76 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.29604712 |
| 77 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.28166552 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26613935 |
| 79 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.26327626 |
| 80 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.24554762 |
| 81 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.24458773 |
| 82 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23982407 |
| 83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.22882213 |
| 84 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.22689783 |
| 85 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21773551 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21047706 |
| 87 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20362956 |
| 88 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19994410 |
| 89 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.19276135 |
| 90 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.19015219 |
| 91 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.18713032 |
| 92 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18634403 |
| 93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18378162 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16631302 |
| 95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16394251 |
| 96 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16384908 |
| 97 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14249707 |
| 98 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13896354 |
| 99 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11537191 |
| 100 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.11514655 |
| 101 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.11465950 |
| 102 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.10482242 |
| 103 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.07605107 |
| 104 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.07605107 |
| 105 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.07280666 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07246576 |
| 107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06818589 |
| 108 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06324792 |
| 109 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04616002 |
| 110 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04507741 |
| 111 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.04153685 |
| 112 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.03683423 |
| 113 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.03171694 |
| 114 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01994102 |
| 115 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01994102 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01456931 |
| 117 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.01037816 |
| 118 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.00792985 |
| 119 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.00631720 |
| 120 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00613034 |
| 121 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.99842524 |
| 122 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.99446847 |
| 123 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99234949 |
| 124 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99211716 |
| 125 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99127297 |
| 126 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98686969 |
| 127 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.93968445 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93789538 |
| 129 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.92710136 |
| 130 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90900211 |
| 131 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88955989 |
| 132 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.88819107 |
| 133 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88556114 |
| 134 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.88547096 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87469576 |
| 136 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86965815 |
| 137 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.84100041 |
| 138 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.83898749 |
| 139 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.83867186 |
| 140 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.83468966 |
| 141 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.81387773 |
| 142 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80068484 |
| 143 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.79910168 |
| 144 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.79858525 |
| 145 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.79853431 |
| 146 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78747306 |
| 147 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78747306 |
| 148 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.78571141 |
| 149 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.78434704 |
| 150 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78399919 |
| 151 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.76658657 |
| 152 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.76547642 |
| 153 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.75950571 |
| 154 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.75531187 |
| 155 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.75503852 |
| 156 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.75445628 |
| 157 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75424910 |
| 158 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.73346911 |
| 159 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72841403 |
| 160 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.72620994 |
| 161 | KDM2B_26808549_Chip-Seq_K562_Human | 0.72160653 |
| 162 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.71541250 |
| 163 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.71323095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 5.92985277 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.13824308 |
| 3 | MP0000751_myopathy | 5.02725368 |
| 4 | MP0000749_muscle_degeneration | 4.72910068 |
| 5 | MP0004036_abnormal_muscle_relaxation | 4.61815182 |
| 6 | MP0003646_muscle_fatigue | 4.42790006 |
| 7 | MP0004215_abnormal_myocardial_fiber | 4.21982690 |
| 8 | MP0005330_cardiomyopathy | 3.82519550 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.69080889 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.34701966 |
| 11 | MP0002972_abnormal_cardiac_muscle | 3.24139642 |
| 12 | MP0005620_abnormal_muscle_contractility | 3.03889345 |
| 13 | MP0008775_abnormal_heart_ventricle | 2.93238933 |
| 14 | * MP0002106_abnormal_muscle_physiology | 2.86734726 |
| 15 | MP0003137_abnormal_impulse_conducting | 2.73361885 |
| 16 | MP0010630_abnormal_cardiac_muscle | 2.66970090 |
| 17 | MP0002269_muscular_atrophy | 2.54486594 |
| 18 | MP0000747_muscle_weakness | 2.50833064 |
| 19 | * MP0000750_abnormal_muscle_regeneration | 2.47912764 |
| 20 | MP0001544_abnormal_cardiovascular_syste | 2.44412525 |
| 21 | MP0005385_cardiovascular_system_phenoty | 2.44412525 |
| 22 | MP0000759_abnormal_skeletal_muscle | 2.33871212 |
| 23 | MP0006138_congestive_heart_failure | 2.32770537 |
| 24 | * MP0005369_muscle_phenotype | 2.32326244 |
| 25 | MP0004233_abnormal_muscle_weight | 2.27661031 |
| 26 | MP0004484_altered_response_of | 2.23240951 |
| 27 | MP0003828_pulmonary_edema | 2.23085942 |
| 28 | MP0004130_abnormal_muscle_cell | 2.22559945 |
| 29 | MP0004085_abnormal_heartbeat | 2.01331917 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.95555063 |
| 31 | MP0002127_abnormal_cardiovascular_syste | 1.87773489 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.84701246 |
| 33 | MP0003567_abnormal_fetal_cardiomyocyte | 1.80858945 |
| 34 | MP0004510_myositis | 1.55994201 |
| 35 | MP0006036_abnormal_mitochondrial_physio | 1.51061329 |
| 36 | MP0000733_abnormal_muscle_development | 1.46015628 |
| 37 | MP0002332_abnormal_exercise_endurance | 1.38989893 |
| 38 | MP0002234_abnormal_pharynx_morphology | 1.26266680 |
| 39 | MP0003279_aneurysm | 1.25852549 |
| 40 | MP0000266_abnormal_heart_morphology | 1.22887032 |
| 41 | MP0002102_abnormal_ear_morphology | 1.08094842 |
| 42 | MP0002108_abnormal_muscle_morphology | 1.07406108 |
| 43 | MP0004272_abnormal_basement_membrane | 1.04579014 |
| 44 | MP0003566_abnormal_cell_adhesion | 0.97310981 |
| 45 | MP0006035_abnormal_mitochondrial_morpho | 0.95166093 |
| 46 | MP0010368_abnormal_lymphatic_system | 0.94117262 |
| 47 | MP0001661_extended_life_span | 0.93141039 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 0.92959368 |
| 49 | MP0005623_abnormal_meninges_morphology | 0.91327604 |
| 50 | MP0003122_maternal_imprinting | 0.89761429 |
| 51 | MP0003283_abnormal_digestive_organ | 0.87614748 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 0.87232609 |
| 53 | MP0001984_abnormal_olfaction | 0.87001066 |
| 54 | MP0002128_abnormal_blood_circulation | 0.86092053 |
| 55 | MP0005165_increased_susceptibility_to | 0.85101628 |
| 56 | MP0009384_cardiac_valve_regurgitation | 0.83786570 |
| 57 | MP0003136_yellow_coat_color | 0.81572795 |
| 58 | MP0005451_abnormal_body_composition | 0.81552268 |
| 59 | MP0000343_altered_response_to | 0.80855155 |
| 60 | MP0005666_abnormal_adipose_tissue | 0.79320566 |
| 61 | MP0008438_abnormal_cutaneous_collagen | 0.78474183 |
| 62 | MP0000767_abnormal_smooth_muscle | 0.75380687 |
| 63 | MP0003045_fibrosis | 0.73260503 |
| 64 | MP0001958_emphysema | 0.72554158 |
| 65 | MP0002638_abnormal_pupillary_reflex | 0.71947150 |
| 66 | MP0001879_abnormal_lymphatic_vessel | 0.69307696 |
| 67 | MP0003123_paternal_imprinting | 0.68569908 |
| 68 | MP0005266_abnormal_metabolism | 0.67766326 |
| 69 | MP0000372_irregular_coat_pigmentation | 0.67134764 |
| 70 | MP0000534_abnormal_ureter_morphology | 0.65830870 |
| 71 | MP0000230_abnormal_systemic_arterial | 0.65018854 |
| 72 | MP0002925_abnormal_cardiovascular_devel | 0.63646620 |
| 73 | MP0000013_abnormal_adipose_tissue | 0.63547712 |
| 74 | MP0002822_catalepsy | 0.62310316 |
| 75 | MP0006276_abnormal_autonomic_nervous | 0.61933855 |
| 76 | MP0005377_hearing/vestibular/ear_phenot | 0.61549740 |
| 77 | MP0003878_abnormal_ear_physiology | 0.61549740 |
| 78 | MP0004270_analgesia | 0.61316617 |
| 79 | MP0004147_increased_porphyrin_level | 0.59458325 |
| 80 | MP0002088_abnormal_embryonic_growth/wei | 0.58716923 |
| 81 | MP0001529_abnormal_vocalization | 0.58670005 |
| 82 | MP0003984_embryonic_growth_retardation | 0.58376986 |
| 83 | MP0004142_abnormal_muscle_tone | 0.58029945 |
| 84 | MP0010030_abnormal_orbit_morphology | 0.57722829 |
| 85 | MP0005375_adipose_tissue_phenotype | 0.57220178 |
| 86 | MP0004185_abnormal_adipocyte_glucose | 0.54952023 |
| 87 | MP0003385_abnormal_body_wall | 0.54155576 |
| 88 | MP0005275_abnormal_skin_tensile | 0.53596541 |
| 89 | MP0004134_abnormal_chest_morphology | 0.53468447 |
| 90 | MP0005171_absent_coat_pigmentation | 0.53178858 |
| 91 | MP0003937_abnormal_limbs/digits/tail_de | 0.51802288 |
| 92 | MP0001784_abnormal_fluid_regulation | 0.51650041 |
| 93 | MP0004924_abnormal_behavior | 0.51541447 |
| 94 | MP0005386_behavior/neurological_phenoty | 0.51541447 |
| 95 | MP0005503_abnormal_tendon_morphology | 0.49529252 |
| 96 | MP0001614_abnormal_blood_vessel | 0.49405567 |
| 97 | MP0002971_abnormal_brown_adipose | 0.45871578 |
| 98 | MP0000003_abnormal_adipose_tissue | 0.45382645 |
| 99 | MP0006072_abnormal_retinal_apoptosis | 0.44589871 |
| 100 | MP0001299_abnormal_eye_distance/ | 0.41772647 |
| 101 | MP0003942_abnormal_urinary_system | 0.40794777 |
| 102 | MP0005253_abnormal_eye_physiology | 0.40031380 |
| 103 | MP0001672_abnormal_embryogenesis/_devel | 0.38592238 |
| 104 | MP0005380_embryogenesis_phenotype | 0.38592238 |
| 105 | MP0005670_abnormal_white_adipose | 0.37711775 |
| 106 | MP0002114_abnormal_axial_skeleton | 0.37073555 |
| 107 | MP0000049_abnormal_middle_ear | 0.36917797 |
| 108 | MP0002272_abnormal_nervous_system | 0.36770240 |
| 109 | MP0009250_abnormal_appendicular_skeleto | 0.35929012 |
| 110 | MP0003755_abnormal_palate_morphology | 0.35701822 |
| 111 | MP0003948_abnormal_gas_homeostasis | 0.35660973 |
| 112 | MP0005187_abnormal_penis_morphology | 0.33526908 |
| 113 | MP0009745_abnormal_behavioral_response | 0.33309244 |
| 114 | MP0003806_abnormal_nucleotide_metabolis | 0.32269112 |
| 115 | MP0000428_abnormal_craniofacial_morphol | 0.31190235 |
| 116 | MP0004197_abnormal_fetal_growth/weight/ | 0.30393658 |
| 117 | MP0003941_abnormal_skin_development | 0.30172611 |
| 118 | MP0004043_abnormal_pH_regulation | 0.29993749 |
| 119 | MP0001727_abnormal_embryo_implantation | 0.29312879 |
| 120 | MP0002896_abnormal_bone_mineralization | 0.28860316 |
| 121 | MP0003121_genomic_imprinting | 0.28751990 |
| 122 | MP0001730_embryonic_growth_arrest | 0.27794579 |
| 123 | MP0009672_abnormal_birth_weight | 0.27604046 |
| 124 | MP0000762_abnormal_tongue_morphology | 0.27201161 |
| 125 | MP0003935_abnormal_craniofacial_develop | 0.26943278 |
| 126 | MP0001697_abnormal_embryo_size | 0.26937310 |
| 127 | MP0008961_abnormal_basal_metabolism | 0.25977423 |
| 128 | MP0005595_abnormal_vascular_smooth | 0.24972508 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.24444743 |
| 130 | MP0005319_abnormal_enzyme/_coenzyme | 0.24221407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.42229649 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 6.51205709 |
| 3 | Exercise-induced myalgia (HP:0003738) | 6.10108951 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 5.86846593 |
| 5 | Subaortic stenosis (HP:0001682) | 5.66443300 |
| 6 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.66443300 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.62562506 |
| 8 | Ventricular tachycardia (HP:0004756) | 5.58864681 |
| 9 | Abnormality of the calf musculature (HP:0001430) | 5.31696219 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 5.17233781 |
| 11 | Muscle fiber splitting (HP:0003555) | 5.15811343 |
| 12 | Atrial fibrillation (HP:0005110) | 5.12905218 |
| 13 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.11497929 |
| 14 | Muscle fiber inclusion bodies (HP:0100299) | 5.10764304 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 4.89452423 |
| 16 | Primary atrial arrhythmia (HP:0001692) | 4.79260241 |
| 17 | Lipoatrophy (HP:0100578) | 4.66270771 |
| 18 | Supraventricular tachycardia (HP:0004755) | 4.63212519 |
| 19 | Myoglobinuria (HP:0002913) | 4.62555524 |
| 20 | Nemaline bodies (HP:0003798) | 4.55680416 |
| 21 | Supraventricular arrhythmia (HP:0005115) | 4.55254150 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 4.55131788 |
| 23 | Right ventricular cardiomyopathy (HP:0011663) | 4.24697576 |
| 24 | Syncope (HP:0001279) | 4.21844235 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 3.96891688 |
| 26 | Ventricular arrhythmia (HP:0004308) | 3.95072457 |
| 27 | Dilated cardiomyopathy (HP:0001644) | 3.82294880 |
| 28 | Prolonged QT interval (HP:0001657) | 3.81907696 |
| 29 | Palpitations (HP:0001962) | 3.74765401 |
| 30 | Increased connective tissue (HP:0009025) | 3.70886014 |
| 31 | Rhabdomyolysis (HP:0003201) | 3.66110715 |
| 32 | Difficulty running (HP:0009046) | 3.51024548 |
| 33 | Myotonia (HP:0002486) | 3.50412696 |
| 34 | Distal arthrogryposis (HP:0005684) | 3.37209249 |
| 35 | Bundle branch block (HP:0011710) | 3.29210034 |
| 36 | Ventricular fibrillation (HP:0001663) | 3.24931717 |
| 37 | Difficulty climbing stairs (HP:0003551) | 3.08649216 |
| 38 | Neck muscle weakness (HP:0000467) | 3.02941076 |
| 39 | Muscle stiffness (HP:0003552) | 2.87229786 |
| 40 | Heart block (HP:0012722) | 2.86247877 |
| 41 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.81604214 |
| 42 | Abnormal EKG (HP:0003115) | 2.80630274 |
| 43 | Atrioventricular block (HP:0001678) | 2.78909140 |
| 44 | Abnormal atrioventricular conduction (HP:0005150) | 2.76591711 |
| 45 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.73575023 |
| 46 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.71053925 |
| 47 | Deformed tarsal bones (HP:0008119) | 2.70218778 |
| 48 | Round ear (HP:0100830) | 2.69010963 |
| 49 | Increased variability in muscle fiber diameter (HP:0003557) | 2.65909792 |
| 50 | Generalized muscle weakness (HP:0003324) | 2.64655585 |
| 51 | Ragged-red muscle fibers (HP:0003200) | 2.63631472 |
| 52 | Left ventricular hypertrophy (HP:0001712) | 2.63572193 |
| 53 | Myopathic facies (HP:0002058) | 2.61028511 |
| 54 | EMG: neuropathic changes (HP:0003445) | 2.54953423 |
| 55 | Abnormal finger flexion creases (HP:0006143) | 2.49712204 |
| 56 | Limited hip movement (HP:0008800) | 2.48133383 |
| 57 | Scapular winging (HP:0003691) | 2.46962394 |
| 58 | Distal lower limb muscle weakness (HP:0009053) | 2.42295320 |
| 59 | Gowers sign (HP:0003391) | 2.42080930 |
| 60 | Areflexia of lower limbs (HP:0002522) | 2.39018606 |
| 61 | Rimmed vacuoles (HP:0003805) | 2.29216529 |
| 62 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.26075335 |
| 63 | Ulnar deviation of the wrist (HP:0003049) | 2.22170059 |
| 64 | Double outlet right ventricle (HP:0001719) | 2.21510114 |
| 65 | Congenital malformation of the right heart (HP:0011723) | 2.21510114 |
| 66 | Conjunctival hamartoma (HP:0100780) | 2.20936796 |
| 67 | Acute necrotizing encephalopathy (HP:0006965) | 2.20414696 |
| 68 | Hypoplastic heart (HP:0001961) | 2.19802477 |
| 69 | Pheochromocytoma (HP:0002666) | 2.19496583 |
| 70 | Palmoplantar keratoderma (HP:0000982) | 2.17200626 |
| 71 | Limb-girdle muscle atrophy (HP:0003797) | 2.16505131 |
| 72 | Malignant hyperthermia (HP:0002047) | 2.10187625 |
| 73 | Abnormality of the foot musculature (HP:0001436) | 2.09549535 |
| 74 | Hepatic necrosis (HP:0002605) | 2.02765811 |
| 75 | Spinal rigidity (HP:0003306) | 2.00956885 |
| 76 | Slender build (HP:0001533) | 2.00626428 |
| 77 | Sudden cardiac death (HP:0001645) | 1.98025236 |
| 78 | Progressive muscle weakness (HP:0003323) | 1.97472649 |
| 79 | Fatigable weakness (HP:0003473) | 1.95727491 |
| 80 | Abnormality of the neuromuscular junction (HP:0003398) | 1.95727491 |
| 81 | Neoplasm of the adrenal gland (HP:0100631) | 1.94466519 |
| 82 | Aplasia of the musculature (HP:0100854) | 1.94300698 |
| 83 | Hypoplastic ischia (HP:0003175) | 1.93781632 |
| 84 | Absent phalangeal crease (HP:0006109) | 1.93045463 |
| 85 | Exercise intolerance (HP:0003546) | 1.92616805 |
| 86 | Type 2 muscle fiber atrophy (HP:0003554) | 1.92289344 |
| 87 | Calcaneovalgus deformity (HP:0001848) | 1.91476880 |
| 88 | Muscular dystrophy (HP:0003560) | 1.91258470 |
| 89 | Neuroendocrine neoplasm (HP:0100634) | 1.90685602 |
| 90 | Frequent falls (HP:0002359) | 1.88125685 |
| 91 | Hip contracture (HP:0003273) | 1.86669335 |
| 92 | Distal lower limb amyotrophy (HP:0008944) | 1.86133274 |
| 93 | Waddling gait (HP:0002515) | 1.84773442 |
| 94 | Weak cry (HP:0001612) | 1.82219707 |
| 95 | Hypoplastic left heart (HP:0004383) | 1.80258875 |
| 96 | Popliteal pterygium (HP:0009756) | 1.80012463 |
| 97 | Foot dorsiflexor weakness (HP:0009027) | 1.79918199 |
| 98 | Progressive macrocephaly (HP:0004481) | 1.79607350 |
| 99 | Bulbar palsy (HP:0001283) | 1.79339370 |
| 100 | Hypoglycemic coma (HP:0001325) | 1.79197774 |
| 101 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.79017919 |
| 102 | Bradycardia (HP:0001662) | 1.78596448 |
| 103 | Fetal akinesia sequence (HP:0001989) | 1.78183759 |
| 104 | Congestive heart failure (HP:0001635) | 1.77830135 |
| 105 | Abnormality of glycolysis (HP:0004366) | 1.77732691 |
| 106 | Increased serum pyruvate (HP:0003542) | 1.77732691 |
| 107 | Acute encephalopathy (HP:0006846) | 1.77577543 |
| 108 | Facial diplegia (HP:0001349) | 1.76816804 |
| 109 | Abnormality of the ischium (HP:0003174) | 1.72782277 |
| 110 | Limb-girdle muscle weakness (HP:0003325) | 1.69072030 |
| 111 | Steppage gait (HP:0003376) | 1.67776974 |
| 112 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.66095185 |
| 113 | Hyperkalemia (HP:0002153) | 1.65298711 |
| 114 | Abnormality of the calcaneus (HP:0008364) | 1.63126808 |
| 115 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.59069239 |
| 116 | Infantile muscular hypotonia (HP:0008947) | 1.57843268 |
| 117 | Muscle fiber atrophy (HP:0100295) | 1.56486487 |
| 118 | Proximal amyotrophy (HP:0007126) | 1.55093710 |
| 119 | Metatarsus adductus (HP:0001840) | 1.51944959 |
| 120 | Preauricular pit (HP:0004467) | 1.48791391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.24593767 |
| 2 | TTN | 4.91789436 |
| 3 | PKN2 | 3.99525841 |
| 4 | STK24 | 3.71286097 |
| 5 | MYLK | 3.55811362 |
| 6 | PHKG1 | 3.51946620 |
| 7 | PHKG2 | 3.51946620 |
| 8 | DMPK | 3.01803618 |
| 9 | PDK3 | 2.94491544 |
| 10 | PDK4 | 2.94491544 |
| 11 | NEK1 | 2.93378775 |
| 12 | TRIB3 | 2.89254809 |
| 13 | LMTK2 | 2.47254412 |
| 14 | PIK3CA | 2.06381620 |
| 15 | MUSK | 2.04956382 |
| 16 | ILK | 2.04841806 |
| 17 | MARK1 | 1.98047741 |
| 18 | LIMK1 | 1.70976828 |
| 19 | PDK2 | 1.67724170 |
| 20 | TIE1 | 1.62856676 |
| 21 | ZAK | 1.62661492 |
| 22 | CDC42BPA | 1.42487271 |
| 23 | FRK | 1.34049552 |
| 24 | BCKDK | 1.30687763 |
| 25 | MAP3K7 | 1.29650436 |
| 26 | PIK3CG | 1.27909773 |
| 27 | TRPM7 | 1.27239014 |
| 28 | PINK1 | 1.20603260 |
| 29 | ROCK1 | 1.16352941 |
| 30 | FLT3 | 1.14663489 |
| 31 | MAP2K3 | 1.12034155 |
| 32 | MAPK12 | 1.10873861 |
| 33 | BMPR1B | 1.07847023 |
| 34 | MAPKAPK3 | 1.06136924 |
| 35 | STK38L | 1.04904946 |
| 36 | PAK3 | 0.97679615 |
| 37 | PTK2B | 0.96925282 |
| 38 | CAMK2D | 0.94192047 |
| 39 | DDR2 | 0.92390646 |
| 40 | PRKD1 | 0.90512133 |
| 41 | EPHA3 | 0.86293146 |
| 42 | DAPK3 | 0.84238829 |
| 43 | EEF2K | 0.84067851 |
| 44 | PRKAA1 | 0.77982080 |
| 45 | NME1 | 0.76075021 |
| 46 | MAP3K10 | 0.75261637 |
| 47 | RIPK1 | 0.73103023 |
| 48 | WNK4 | 0.71871997 |
| 49 | PRKAA2 | 0.70663369 |
| 50 | PDGFRA | 0.68932836 |
| 51 | CASK | 0.68783801 |
| 52 | MAP3K5 | 0.68365756 |
| 53 | MAPK13 | 0.65944000 |
| 54 | NEK9 | 0.64119829 |
| 55 | ERBB3 | 0.63642379 |
| 56 | ROCK2 | 0.63639183 |
| 57 | ADRBK2 | 0.62653493 |
| 58 | MOS | 0.60136094 |
| 59 | PNCK | 0.59668392 |
| 60 | TESK1 | 0.58812105 |
| 61 | GRK7 | 0.55668311 |
| 62 | STK4 | 0.55086279 |
| 63 | MET | 0.54912621 |
| 64 | CAMK4 | 0.53954006 |
| 65 | AKT2 | 0.53566907 |
| 66 | CCNB1 | 0.53345604 |
| 67 | ADRBK1 | 0.53319030 |
| 68 | MAP4K2 | 0.51420773 |
| 69 | CAMK1 | 0.49567437 |
| 70 | KSR2 | 0.49189578 |
| 71 | KDR | 0.48243281 |
| 72 | WNK3 | 0.48112491 |
| 73 | CAMK1G | 0.47251759 |
| 74 | STK39 | 0.47150019 |
| 75 | GRK1 | 0.46967618 |
| 76 | MAP3K3 | 0.46673732 |
| 77 | CAMK2A | 0.45716559 |
| 78 | LATS2 | 0.45276329 |
| 79 | MAPK7 | 0.44935928 |
| 80 | PRKACB | 0.44910667 |
| 81 | AKT3 | 0.43628565 |
| 82 | SIK1 | 0.43577536 |
| 83 | PAK2 | 0.42422076 |
| 84 | MAP3K4 | 0.41680638 |
| 85 | WNK1 | 0.40223037 |
| 86 | TNIK | 0.39945715 |
| 87 | PRKD3 | 0.39501892 |
| 88 | PLK2 | 0.39155113 |
| 89 | PTK6 | 0.38394398 |
| 90 | LRRK2 | 0.38054710 |
| 91 | RET | 0.37884468 |
| 92 | DYRK1B | 0.37101384 |
| 93 | UHMK1 | 0.36048077 |
| 94 | CAMK2G | 0.35611170 |
| 95 | MAP2K1 | 0.35473497 |
| 96 | EPHB2 | 0.35287373 |
| 97 | CAMK2B | 0.34021078 |
| 98 | FGFR1 | 0.33999539 |
| 99 | LATS1 | 0.31663075 |
| 100 | INSRR | 0.30366338 |
| 101 | STK11 | 0.29727221 |
| 102 | PRKACA | 0.29520511 |
| 103 | NTRK3 | 0.28843237 |
| 104 | STK38 | 0.27861665 |
| 105 | EPHA4 | 0.27822127 |
| 106 | MAPK4 | 0.26920645 |
| 107 | FER | 0.26502464 |
| 108 | PTK2 | 0.25766357 |
| 109 | RPS6KL1 | 0.24666226 |
| 110 | RPS6KC1 | 0.24666226 |
| 111 | RPS6KA3 | 0.24545092 |
| 112 | MAP2K4 | 0.24472023 |
| 113 | MARK3 | 0.24356102 |
| 114 | PRKACG | 0.24331713 |
| 115 | MTOR | 0.24321040 |
| 116 | BRSK2 | 0.24075579 |
| 117 | PAK6 | 0.23620139 |
| 118 | SGK2 | 0.23234680 |
| 119 | NTRK2 | 0.23106602 |
| 120 | RPS6KA2 | 0.22582952 |
| 121 | PRKG1 | 0.22062558 |
| 122 | PRKG2 | 0.20738024 |
| 123 | NME2 | 0.20112551 |
| 124 | TGFBR2 | 0.19877891 |
| 125 | STK3 | 0.18594729 |
| 126 | MAPK11 | 0.16696042 |
| 127 | PKN1 | 0.16583028 |
| 128 | RPS6KB2 | 0.15375986 |
| 129 | PRKCE | 0.14970448 |
| 130 | ICK | 0.14188154 |
| 131 | RPS6KA6 | 0.13988268 |
| 132 | PDK1 | 0.13779000 |
| 133 | MAPKAPK2 | 0.13420355 |
| 134 | PDPK1 | 0.12960396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.82509312 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.77706482 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.28917903 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.17067865 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.94927023 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.11148363 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.07644772 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.81031532 |
| 9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.37703662 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.37544220 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.23346210 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.18463792 |
| 13 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.17931934 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.17180418 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 1.97919588 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.93706831 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.72149685 |
| 18 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.67706483 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.57827880 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.51531869 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51157224 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.37766853 |
| 23 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.35783749 |
| 24 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.31458947 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26465890 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25501283 |
| 27 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.22500535 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.19490582 |
| 29 | Insulin resistance_Homo sapiens_hsa04931 | 1.14833481 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 1.14484958 |
| 31 | Tight junction_Homo sapiens_hsa04530 | 1.07140968 |
| 32 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.07020365 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.04149640 |
| 34 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.03996745 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00141821 |
| 36 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.98341608 |
| 37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92517150 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.88152706 |
| 39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85485812 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 0.84993945 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.83429424 |
| 42 | GABAergic synapse_Homo sapiens_hsa04727 | 0.83162267 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82414786 |
| 44 | Morphine addiction_Homo sapiens_hsa05032 | 0.82064652 |
| 45 | Salivary secretion_Homo sapiens_hsa04970 | 0.81638947 |
| 46 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.81512040 |
| 47 | Adherens junction_Homo sapiens_hsa04520 | 0.81209602 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80102386 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77673827 |
| 50 | Taste transduction_Homo sapiens_hsa04742 | 0.71244079 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67917851 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67735446 |
| 53 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66587691 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65635549 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65199114 |
| 56 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.64039767 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63614379 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59156169 |
| 59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58359643 |
| 60 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.58039904 |
| 61 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.56196109 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55420056 |
| 63 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54262069 |
| 64 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.53894035 |
| 65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53632458 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52776890 |
| 67 | Axon guidance_Homo sapiens_hsa04360 | 0.51283069 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50594953 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.50228052 |
| 70 | Melanoma_Homo sapiens_hsa05218 | 0.49242896 |
| 71 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49160548 |
| 72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48920698 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.48750819 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47971495 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.47766089 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47591345 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46939168 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46534047 |
| 79 | Long-term depression_Homo sapiens_hsa04730 | 0.46382264 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.45630780 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45032189 |
| 82 | Insulin secretion_Homo sapiens_hsa04911 | 0.42380693 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42335634 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42082912 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.39858338 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39018831 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38327825 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.38142410 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37846328 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37546117 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.36630864 |
| 92 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.36622683 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36283224 |
| 94 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.36157554 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34939393 |
| 96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.34579148 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33354028 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.32530822 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31954774 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30638640 |
| 101 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.29837685 |
| 102 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.27139802 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26227007 |
| 104 | Melanogenesis_Homo sapiens_hsa04916 | 0.25178886 |
| 105 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.22536481 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22374408 |
| 107 | Gap junction_Homo sapiens_hsa04540 | 0.21677903 |
| 108 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.21175662 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.21135750 |
| 110 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.20310921 |
| 111 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.18993002 |
| 112 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.18850793 |
| 113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.17772817 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.16700107 |
| 115 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.16686478 |
| 116 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.16556758 |
| 117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.16443170 |
| 118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.16168905 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.14779251 |
| 120 | Olfactory transduction_Homo sapiens_hsa04740 | 0.14770894 |
| 121 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.14584834 |
| 122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14174772 |
| 123 | Thyroid cancer_Homo sapiens_hsa05216 | 0.12883820 |
| 124 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.11865845 |
| 125 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.11723306 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.10115350 |
| 127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.09430770 |
| 128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.07912450 |
| 129 | Long-term potentiation_Homo sapiens_hsa04720 | 0.07374499 |
| 130 | Pathways in cancer_Homo sapiens_hsa05200 | 0.07292923 |

